These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 25998972

  • 1. [Changing paradigm in the management of inflammatory bowel disease].
    Jang BI.
    Korean J Gastroenterol; 2015 May; 65(5):268-72. PubMed ID: 25998972
    [Abstract] [Full Text] [Related]

  • 2. Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD.
    Molander P, Sipponen T, Kemppainen H, Jussila A, Blomster T, Koskela R, Nissinen M, Rautiainen H, Kuisma J, Kolho KL, Färkkilä M.
    J Crohns Colitis; 2013 Oct; 7(9):730-5. PubMed ID: 23182163
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F, Portela F.
    BioDrugs; 2010 Dec 14; 24 Suppl 1():3-14. PubMed ID: 21175228
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical implications of mucosal healing in the management of patients with inflammatory bowel disease.
    Orlando A, Guglielmi FW, Cottone M, Orlando E, Romano C, Sinagra E.
    Dig Liver Dis; 2013 Dec 14; 45(12):986-91. PubMed ID: 23993738
    [Abstract] [Full Text] [Related]

  • 10. New strategies in the management of inflammatory bowel disease.
    Rutgeerts P, Baert F.
    Acta Clin Belg; 1999 Oct 14; 54(5):274-80. PubMed ID: 10555385
    [Abstract] [Full Text] [Related]

  • 11. Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5'-aminosalicylate treatment.
    Siddique I, Hasan F, Khan I.
    Scand J Gastroenterol; 2009 Oct 14; 44(1):56-64. PubMed ID: 18785066
    [Abstract] [Full Text] [Related]

  • 12. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L, Kuiper I, Lamers CB, Verspaget HW.
    J Pathol; 2003 Sep 14; 201(1):28-36. PubMed ID: 12950014
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Current therapeutic approaches in inflammatory bowel disease.
    Sohrabpour AA, Malekzadeh R, Keshavarzian A.
    Curr Pharm Des; 2010 Sep 14; 16(33):3668-83. PubMed ID: 21128898
    [Abstract] [Full Text] [Related]

  • 16. EHealth: self-management in inflammatory bowel disease and in irritable bowel syndrome using novel constant-care web applications. EHealth by constant-care in IBD and IBS.
    Pedersen N.
    Dan Med J; 2015 Dec 14; 62(12):B5168. PubMed ID: 26621403
    [Abstract] [Full Text] [Related]

  • 17. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease.
    Breese EJ, Michie CA, Nicholls SW, Murch SH, Williams CB, Domizio P, Walker-Smith JA, MacDonald TT.
    Gastroenterology; 1994 Jun 14; 106(6):1455-66. PubMed ID: 8194690
    [Abstract] [Full Text] [Related]

  • 18. Intraintestinal Heterogeneity of Drug Target Expression in Inflammatory Bowel Disease.
    Swanson K, Younes M.
    Ann Clin Lab Sci; 2024 Mar 14; 54(2):156-159. PubMed ID: 38802165
    [Abstract] [Full Text] [Related]

  • 19. Collagenous colitis development occurs after long standing mucosal healing in IBD with TNF-α inhibitors, and could be due to exaggerated healing response from excess TNF-α inhibition.
    Saad RE, Shobar R, Mutlu EA.
    Med Hypotheses; 2019 Feb 14; 123():90-94. PubMed ID: 30696605
    [Abstract] [Full Text] [Related]

  • 20. Influence of treatment on morphological features of mucosal inflammation.
    Geboes K, Dalle I.
    Gut; 2002 May 14; 50 Suppl 3(Suppl 3):III37-42. PubMed ID: 11953331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.